Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.
Kobobun. K K; O'Donohue. T L TL; Handelmann. G E GE; Sawyer. T K TK; Hruby. V J VJ; Hadley. M E ME
Key Findings
- Melanotan‑I is equally effective as alpha‑MSH at inducing grooming when given directly into the brain
- Unlike alpha‑MSH, melanotan‑I reduces performance on a visual discrimination (learning) task
- The peptide likely acts as an antagonist at CNS melanocortin receptors that support learning and attention
Practical Outcomes
- If you’re using melanotan‑I for skin tanning or other purposes, be aware it may impair cognitive tasks that require focus and learning. It doesn’t appear to boost mental performance and could be counter‑productive for anyone seeking cognitive or physical performance gains. Use with caution, especially before activities that demand sharp attention.
Summary
The study shows that melanotan‑I (a modified alpha‑MSH) triggers the same grooming behavior as the natural hormone but actually worsens performance on a visual learning test, suggesting it might block brain receptors involved in attention and memory.
Abstract
The behavioral effects of alpha-melanocyte stimulating hormone (alpha-MSH) were compared to an alpha-MSH analogue that had a norleucine substituted for methionine in the four position and a D-phenylalanine substituted for L-phenylalanine in the seven position. [Nle4, D-Phe7]-alpha-MSH has previously been shown to be a superpotent agonist on melanocytes [17]. The present experiments indicate that [Nle4, D-Phe7]-alpha-MSH is equipotent to alpha-MSH in inducing grooming when administered intraventricularly. In contrast, the analogue has the opposite effect of alpha-MSH on performance of a visual discrimination task. alpha-MSH improves visual performance whereas [Nle4, D-Phe7]-alpha-MSH attenuates such performance. The contrasting activities of [Nle4, D-Phe7]-alpha-MSH on the physiological processes described suggest that this analogue may interact with three distinct melanotropin receptors in different ways. On melanocyte receptors the melanotropin analogue is a superagonist, on CNS melanotropin receptors involved in grooming it is equipotent to alpha-MSH, and on CNS receptors involved in attention, learning and memory [Nle4, D-Phe7]-alpha-MSH may be an antagonist of endogenous melanotropin.
Study Information
pubmed
1983
1983-09-01T00:00:00.000Z
10.1016/0196-9781(83)90025-6
25
16